Survival of patients treated with radiation therapy for anaplastic astrocytoma

1. CBTRUS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2007. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2011.Search in Google Scholar

2. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003; 99: 467-73.10.3171/jns.2003.99.3.0467Search in Google Scholar

3. Walker MD, Hunt WE, Mahaley MS, Norrell HA, Ransohoff J, Gehan EA. Evaluation of Bcnu and-or radiotherapy in treatment of anaplastic gliomas- -cooperative clinical-trial. J Neurosurg 1978; 49: 333-43.10.3171/jns.1978.49.3.0333Search in Google Scholar

4. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Stat M, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649-52.10.1002/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-WSearch in Google Scholar

5. Curran WJ, Jr., Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-10.10.1093/jnci/85.9.704Search in Google Scholar

6. Mehta MP, Siker ML, Chakravarti A. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Crit Rev Oncol Hematol 2006; 60: 99-111.Search in Google Scholar

7. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-66.10.1016/S1470-2045(09)70025-7Search in Google Scholar

8. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96.10.1056/NEJMoa043330Search in Google Scholar

9. Smrdel U, Kovac V, Popovic M, Zwitter M. Glioblastoma patients in Slovenia from 1997 to 2008. Radiol Oncol 2014; 48: 72-9.10.2478/raon-2014-0002Search in Google Scholar

10. Yung WKA, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 1999; 17: 2762-71.10.1200/JCO.1999.17.9.2762Search in Google Scholar

11. Kim YH, Park CK, Cho WH, Kim IA, Moon S, Choe G, et al. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study. J Neurooncol 2011; 103: 503-12.10.1007/s11060-010-0404-5Search in Google Scholar

12. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998; 40: 51-5.10.1016/S0360-3016(97)00485-9Search in Google Scholar

13. Combs SE, Nagy M, Edler L, Rausch R, Bischof M, Welzel T, et al. Comparative evaluation of radiochemotherapy with temozolomide versus standard-ofcare postoperative radiation alone in patients with WHO grade III astrocytic tumors. Radiother Oncol 2008; 88: 177-82.10.1016/j.radonc.2008.03.005Search in Google Scholar

14. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (Aaf)--a report from 3 Radiation-Therapy-Oncology-Group (RTOG) trials. J Neuro-Oncol 1992; 12: 219-27.10.1007/BF00172709Search in Google Scholar

15. Compostella A, Tosoni A, Blatt V, Franceschi E, Brandes AA. Prognostic factors for anaplastic astrocytomas. J Neurooncol 2007; 81: 295-303.10.1007/s11060-006-9232-zSearch in Google Scholar

16. Graus F, Tortosa A, Vinolas N, Villa S, Verger E, Gil JM, et al. Prognostic pathologic implication of clinical, radiologic, and features in patients with anaplastic gliomas. Cancer 2003; 97: 1063-71.10.1002/cncr.11120Search in Google Scholar

17. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, et al. Highly anaplastic astrocytoma--a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992; 23: 3-8.10.1016/0360-3016(92)90537-RSearch in Google Scholar

18. L aramore GE, Martz KL, Nelson JS, Griffin TW, Chang CH, Horton J. Radiation-Therapy Oncology Group (Rtog) survival-data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? Int J Radiat Oncol Biol Phys 1989; 17: 1351-6.Search in Google Scholar